Zhi-Yu Li (Zhiyu Li)

Publication Activity (10 Years)

Years Active: 2018-2023
Publications (10 Years): 4

Top Topics

Human Serum Albumin

Men Who Have Sex With Men

Top Venues

ACS medicinal chemistry letters

Molecular pharmaceutics

Journal of computer-aided molecular design

This page only lists publications with an associated author ORCID identifier.

Publications

Yan-Kai Wang, Xu-Sheng Huang, Hao Sun, Meng-Di Ma, Hai-Peng Yu, Wei Hu, Zhi-Yu Li, Zhong Li, Rong-Hua Luo, Ren-Rong Tian, Tai-Fu Xiao, Liu-Meng Yang, Yong-Tang Zheng, Xun Li
Novel Triazolopyridine-Based BRD4 Inhibitors as Potent HIV-1 Latency Reversing Agents. ACS medicinal chemistry letters 15 (1) (2023)
Yan-Kai Wang, Xu-Sheng Huang, Hao Sun, Meng-Di Ma, Hai-Peng Yu, Wei Hu, Zhi-Yu Li, Zhong Li, Rong-Hua Luo, Ren-Rong Tian, Tai-Fu Xiao, Liu-Meng Yang, Yong-Tang Zheng, Xun Li
Novel Triazolopyridine-Based BRD4 Inhibitors as Potent HIV-1 Latency Reversing Agents. ACS medicinal chemistry letters 15 (1) (2023)
Tejashree Redij, Jian Ma, Zhi-Yu Li, Xianxin Hua, Zhijun Li
Discovery of a potential positive allosteric modulator of glucagon-like peptide 1 receptor through virtual screening and experimental study. Journal of computer-aided molecular design 33 (11) (2019)
Ivana Roscoe, Michelle Parker, Daoyuan Dong, Xun Li, Zhi-Yu Li
Human Serum Albumin and the p53-Derived Peptide Fusion Protein Promotes Cytotoxicity Irrespective of p53 Status in Cancer Cells. Molecular pharmaceutics 15 (11) (2018)